Determination of Anti-Adeno-Associated Viral Vector Neutralizing Antibodies in Patients With Heart Failure in the Cardiovascular Foundation of Colombia (ANVIAS): Study Protocol.
Melvin Y RinconCarlos E PradaM Marcos LopezVíctor A CastilloLuis Eduardo EcheverriaNorma Cecilia SerranoPublished in: JMIR research protocols (2016)
This project is the first effort to evaluate NAb levels against AAV1, AAV2, and AAV9 serotypes in patients with HF in Latin America. Our results will allow us to check the cross-reactivity response between the serotypes assessed, to describe the epidemiological characteristics of the participant population, and to set up a link with earlier reports of NAb prevalence in the literature.
Keyphrases
- gene therapy
- study protocol
- advanced non small cell lung cancer
- randomized controlled trial
- systematic review
- risk factors
- sars cov
- quality improvement
- clinical trial
- solid phase extraction
- dengue virus
- emergency department
- open label
- heart failure
- zika virus
- high resolution
- epidermal growth factor receptor
- drug induced